We’ve learned a lot from lymphocytic choriomeningitis virus—now the time has come to fight it
Key Findings: There are no vaccines or therapies available for lymphocytic choriomeningitis virus (LCMV) infection. This pathogen spreads easily and
LJI Professor Alessandro Sette elected to the American Academy of Microbiology
Sette has led investigations into the T cell response to SARS-CoV-2, tuberculosis, and more
Lasting relief may be on the horizon for patients with atopic dermatitis
LJI research collaboration with Kyowa Kirin Co., Ltd., points to a novel approach to treat the most common form of eczema
New $17 million grant establishes LJI as global hub for immunology data curation and analysis
NIAID support opens gateway to new research into human immune responses to viruses, the development of autoimmune diseases, and more
LJI scientists uncover the structure and function of Inmazeb, the first FDA-approved drug for Ebola virus infection
LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved
Shane Crotty receives AAI-BioLegend Herzenberg Award for B cell research
LA JOLLA, CA—La Jolla Institute for Immunology (LJI) Professor Shane Crotty, Ph.D., has been awarded the 2023 AAI-BioLegend Herzenberg Award
Durable SARS-CoV-2 antibodies bind to two viral targets at once
A new study led by scientists at La Jolla Institute for Immunology (LJI) shows how ideal antibodies against SARS-CoV-2 hit their marks.
LJI scientists solve the mystery of why OGT enzyme is critical for cell survival
LA JOLLA, CA — Researchers at La Jolla Institute for Immunology (LJI) have at last uncovered how an enzyme called
LJI Instructor Annie Elong Ngono, Ph.D., wins GVN support to advance infectious disease research
LA JOLLA—As an infectious disease researcher at La Jolla Institute for Immunology (LJI) Instructor Annie Elong Ngono, Ph.D., has spearheaded
LJI researchers find missing piece of the asthma puzzle
New study reveals how the inflammatory "LIGHT" protein leads to airway remodeling and long-term breathing issues
LJI scientists confirm smallpox vaccine also teaches T cells to fight mpox
LA JOLLA, CA—There’s even more reason to think a vaccine developed against smallpox can help the body fight against mpox
LJI Board of Directors welcomes four new members
Institute strengthens its leadership going into 2023